These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 32399681
1. Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli. Bandyopadhyay D, Mukherjee M. Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1753-1760. PubMed ID: 32399681 [Abstract] [Full Text] [Related]
2. Combination of bactericidal antibiotics and inhibitors of Universal stress protein A (UspA): a potential therapeutic alternative against multidrug resistant Escherichia coli in urinary tract infections. Bandyopadhyay D, Mukherjee M. J Antibiot (Tokyo); 2022 Jan; 75(1):21-28. PubMed ID: 34526667 [Abstract] [Full Text] [Related]
3. Treating urinary tract infections due to MDR E. coli with Isothiocyanates - a phytotherapeutic alternative to antibiotics? Mutters NT, Mampel A, Kropidlowski R, Biehler K, Günther F, Bălu I, Malek V, Frank U. Fitoterapia; 2018 Sep; 129():237-240. PubMed ID: 30031115 [Abstract] [Full Text] [Related]
4. Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli. Ibrahim AA, Mohammed RK. Braz J Microbiol; 2024 Jun; 55(2):1091-1097. PubMed ID: 38367167 [Abstract] [Full Text] [Related]
5. Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli. Javed S, Mirani ZA, Pirzada ZA. Pak J Pharm Sci; 2020 Nov; 33(6):2643-2649. PubMed ID: 33867342 [Abstract] [Full Text] [Related]
6. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lee JH, Subhadra B, Son YJ, Kim DH, Park HS, Kim JM, Koo SH, Oh MH, Kim HJ, Choi CH. Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617 [Abstract] [Full Text] [Related]
7. Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains. Adamus-Białek W, Wawszczak M, Arabski M, Majchrzak M, Gulba M, Jarych D, Parniewski P, Głuszek S. Virulence; 2019 Dec; 10(1):260-276. PubMed ID: 30938219 [Abstract] [Full Text] [Related]
8. Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic Escherichia coli Isolates from Patients with Urinary Tract Infections in a Tertiary Teaching Hospital in Iran. Neamati F, Khorshidi A, Moniri R, Hosseini Tafreshi SA. Microb Drug Resist; 2020 Jan; 26(1):60-70. PubMed ID: 31526226 [Abstract] [Full Text] [Related]
9. Effect of sub-minimal inhibitory concentration ceftazidime on the pathogenicity of uropathogenic Escherichia coli. Feng W, Zhang L, Yuan Q, Wang Y, Yao P, Xia P, Sun F. Microb Pathog; 2021 Feb; 151():104748. PubMed ID: 33484810 [Abstract] [Full Text] [Related]
10. Investigation of antibiotic resistance determinants and virulence factors of uropathogenic Escherichia coli. Sun DH, Lv DF, Mi ZH, Hu LQ, Huang Y, Gao X, Weng XB. J Antibiot (Tokyo); 2020 May; 73(5):314-319. PubMed ID: 32076117 [Abstract] [Full Text] [Related]
11. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. Moreira da Silva RCR, de Oliveira Martins Júnior P, Gonçalves LF, de Paulo Martins V, de Melo ABF, Pitondo-Silva A, de Campos TA. J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868 [Abstract] [Full Text] [Related]
12. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates. Liu X, Lazzaroni C, Aly SA, Thungrat K, Boothe DM. Vet Microbiol; 2014 Dec 05; 174(3-4):514-522. PubMed ID: 25465666 [Abstract] [Full Text] [Related]
13. Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba. Regasa Dadi B, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. J Infect Dev Ctries; 2018 Aug 31; 12(8):608-615. PubMed ID: 31958322 [Abstract] [Full Text] [Related]
14. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. Shah C, Baral R, Bartaula B, Shrestha LB. BMC Microbiol; 2019 Sep 02; 19(1):204. PubMed ID: 31477018 [Abstract] [Full Text] [Related]
15. Repurposing carvacrol, cinnamaldehyde, and eugenol as potential anti-quorum sensing agents against uropathogenic Escherichia coli isolates in Alexandria, Egypt. Morgaan HA, Omar HMG, Zakaria AS, Mohamed NM. BMC Microbiol; 2023 Oct 23; 23(1):300. PubMed ID: 37872476 [Abstract] [Full Text] [Related]
16. In Vitro Activity of Fosfomycin in Double and Triple Combinations with Imipenem, Ciprofloxacin and Tobramycin Against Multidrug-Resistant Escherichia coli. El-Wafa WMA, Ibrahim YM. Curr Microbiol; 2020 May 23; 77(5):755-761. PubMed ID: 31919670 [Abstract] [Full Text] [Related]
18. Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections. Fallah F, Karimi A, Goudarzi M, Shiva F, Navidinia M, Jahromi MH, Sajadi Nia RS. Microb Drug Resist; 2012 Dec 23; 18(6):546-9. PubMed ID: 22816551 [Abstract] [Full Text] [Related]
19. Association of Virulence Genes with Antibiotic Resistance in Pakistani Uropathogenic E. coli Isolates. Haq KU, Noreen S, Sehgal SA, Tahir RA, Essa A, Ihsan A, Hassan MU, Iqbal W, Hussain M, Hussain H, Siraj S. Comb Chem High Throughput Screen; 2020 Dec 23; 23(6):517-524. PubMed ID: 32238138 [Abstract] [Full Text] [Related]
20. Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis. Hadifar S, Moghoofei M, Nematollahi S, Ramazanzadeh R, Sedighi M, Salehi-Abargouei A, Miri A. Jpn J Infect Dis; 2017 Jan 24; 70(1):19-25. PubMed ID: 27000462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]